Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion type Assertion NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_head.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion description "[Despite the high incidence of revertant mosaicism (35%) in patients with the genetic skin disease epidermolysis bullosa (EB) due to correcting mutations in the genes COL17A1 and LAMB3, revertant mosaicism has not been described for COL7A1 until recently.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_provenance.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion evidence source_evidence_literature NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_provenance.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion SIO_000772 20574443 NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_provenance.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion wasDerivedFrom befree-20140225 NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_provenance.
- NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_assertion wasGeneratedBy ECO_0000203 NP583531.RAIYK-SCcJ_7kAPi4BOa0r8opR8qmn-9BdfNDI5UburDQ130_provenance.